Verastem Fundamentals

VSTM -  USA Stock  

USD 2.76  0.01  0.36%

Verastem fundamentals help investors to digest information that contributes to Verastem's financial success or failures. It also enables traders to predict the movement of Verastem Stock. This fundamental analysis module provides a way for investors to measures Verastem's intrinsic value by examining all of its available economic and financial indicators and drivers, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Verastem stock. Please note, this module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Verastem Fundamentals 

 
Refresh
Verastem Preferred Dividends Income Statement Impact is relatively stable at the moment as compared to the past year. The company's current value of Preferred Dividends Income Statement Impact is estimated at 7,082. Weighted Average Shares is expected to hike to about 165.4 M this year, although the value of Earning Before Interest and Taxes EBIT will most likely fall to (71.8 M).

Verastem Return On Equity Analysis

Verastem's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Return on Equity 
 = 
Net Income 
Total Equity 
X
100 
More About Return On Equity | All Equity Analysis

Current Verastem Return On Equity

    
  (38.17) %  
Most of Verastem's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Verastem is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Compare to competition

Verastem Shareholders Equity

Shareholders Equity

92.61 MillionShare
Verastem Shareholders Equity is relatively stable at the moment as compared to the past year. The company's current value of Shareholders Equity is estimated at 92.61 Million
Based on the latest financial disclosure, Verastem has a Return On Equity of -38.17%. This is 59.24% higher than that of the Healthcare sector and 4.69% higher than that of the Biotechnology industry. The return on equity for all United States stocks is notably higher than that of the company.

Verastem Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Verastem's current stock value. Our valuation model uses many indicators to compare Verastem value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Verastem competition to find correlations between indicators driving Verastem's intrinsic value. More Info.
Verastem is rated fourth in ebitda category among related companies. It is rated third in total asset category among related companies . . Verastem Earnings Before Interest Taxes and Depreciation Amortization EBITDA are relatively stable at the moment as compared to the past year. The company's current value of Earnings Before Interest Taxes and Depreciation Amortization EBITDA is estimated at (54.98 Million)

Verastem Debt to Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Verastem's direct or indirect competition against its Debt to Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Verastem could also be used in its relative valuation, which is a method of valuing Verastem by comparing valuation metrics of similar companies.
Verastem is currently under evaluation in debt to equity category among related companies.

Verastem Current Valuation Drivers

We derive many important indicators used in calculating different scores of Verastem from analyzing Verastem's financial statements. These drivers represent accounts that assess Verastem's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Verastem's important valuation drivers and their relationship over time.
201620172018201920202021 (projected)
Net Income Per Employee(1.14 M)(982.64 K)(428.6 K)(1.11 M)(1.41 M)(1.52 M)
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(36.33 M)(67.25 M)(67.8 M)(131.01 M)(50.96 M)(54.98 M)

Verastem Fundamentals

About Verastem Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Verastem's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Verastem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Verastem based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2021
Revenues88.5 M95.5 M
Revenue to Assets 0.57  0.62 
Revenue Per Employee1.8 MM
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing medicines to enhance the life of cancer patients. The company was incorporated in 2010 and is headquartered in Needham, Massachusetts. Verastem operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 48 people.

Verastem Investors Sentiment

The influence of Verastem's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Verastem. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - VSTM

Verastem Investor Sentiment

Most of Macroaxis users are at this time bullish on Verastem. What is your outlook on investing in Verastem? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity..
Also, please take a look at Verastem Piotroski F Score and Verastem Altman Z Score analysis. Note that the Verastem information on this page should be used as a complementary analysis to other Verastem's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for Verastem Stock analysis

When running Verastem price analysis, check to measure Verastem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verastem is operating at the current time. Most of Verastem's value examination focuses on studying past and present price action to predict the probability of Verastem's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Verastem's price. Additionally, you may evaluate how the addition of Verastem to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
The market value of Verastem is measured differently than its book value, which is the value of Verastem that is recorded on the company's balance sheet. Investors also form their own opinion of Verastem's value that differs from its market value or its book value, called intrinsic value, which is Verastem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verastem's market value can be influenced by many factors that don't directly affect Verastem underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verastem's value and its price as these two are different measures arrived at by different means. Investors typically determine Verastem value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verastem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.